CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Other Current Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$16.00K, a 108.94% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2023 was -$160.00K, a 331.88% decline from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2022 was $69.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2021 was -$1.24M.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2020 was -$55.00K, a 147.83% decline from fiscal 2019.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | -$16.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $0.00 S-4/A · filed 2026-07-22 | $0.00 derived: sum of 2 quarters · filed 2026-07-22 | -$16.00K derived: sum of 3 quarters · filed 2026-07-22 | -$10.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | -$16.00K derived: sum of 2 quarters · filed 2026-07-22 | -$10.00K derived: sum of 3 quarters · filed 2026-08-04 | -$5.00K S-4/A · filed 2026-07-22 | ||
| 2025-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$10.00K derived: sum of 2 quarters · filed 2026-08-04 | -$5.00K 10-Q · filed 2025-11-12 | -$179.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $6.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $11.00K 10-Q · filed 2026-08-04 | -$163.00K derived: sum of 3 quarters · filed 2026-08-04 | $16.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $5.00K S-4/A · filed 2026-07-22 | -$169.00K derived: sum of 2 quarters · filed 2026-07-22 | $10.00K derived: sum of 3 quarters · filed 2026-07-22 | $10.00K derived: sum of 4 quarters · filed 2026-07-22 | ||
| 2024-12-31 | -$174.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $5.00K derived: sum of 2 quarters · filed 2026-07-22 | $5.00K derived: sum of 3 quarters · filed 2026-07-22 | $5.00K S-4/A · filed 2026-07-22 | ||
| 2024-09-30 | $179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $179.00K derived: sum of 2 quarters · filed 2025-11-12 | $179.00K 10-Q · filed 2025-11-12 | $0.00 10-Q · filed 2024-11-14 | $159.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | -$20.00K derived: sum of 3 quarters · filed 2025-11-12 | -$51.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | -$20.00K derived: sum of 2 quarters · filed 2025-11-12 | -$51.00K derived: sum of 3 quarters · filed 2025-11-12 | -$126.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2023-12-31 | -$20.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | -$51.00K derived: sum of 2 quarters · filed 2025-11-12 | -$126.00K derived: sum of 3 quarters · filed 2025-11-12 | -$160.00K 10-K/A · filed 2025-11-12 | ||
| 2023-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$106.00K derived: sum of 2 quarters · filed 2024-11-14 | -$140.00K 10-Q · filed 2024-11-14 | -$91.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$109.00K 10-Q · filed 2024-08-07 | -$60.00K derived: sum of 3 quarters · filed 2024-08-07 | -$54.00K derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | -$34.00K 10-Q · filed 2024-05-07 | $15.00K derived: sum of 2 quarters · filed 2024-05-07 | $21.00K derived: sum of 3 quarters · filed 2024-05-07 | $26.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $55.00K derived: sum of 2 quarters · filed 2024-03-05 | $60.00K derived: sum of 3 quarters · filed 2024-03-05 | $69.00K 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $11.00K derived: sum of 2 quarters · filed 2023-11-13 | $20.00K 10-Q · filed 2023-11-13 | $30.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $14.00K 10-Q · filed 2023-07-28 | $24.00K derived: sum of 3 quarters · filed 2023-07-28 | -$1.35M derived: sum of 4 quarters · filed 2023-07-28 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-12 | $19.00K derived: sum of 2 quarters · filed 2023-05-12 | -$1.36M derived: sum of 3 quarters · filed 2023-05-12 | -$1.33M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$1.36M derived: sum of 2 quarters · filed 2023-03-22 | -$1.34M derived: sum of 3 quarters · filed 2023-03-22 | -$1.24M 10-K · filed 2023-03-22 | $1.24M 10-K · filed 2022-02-24 | |
| 2021-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.35M derived: sum of 2 quarters · filed 2022-11-03 | -$1.25M 10-Q · filed 2022-11-03 | -$1.32M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $121.00K 10-Q · filed 2022-08-09 | $58.00K derived: sum of 3 quarters · filed 2022-08-09 | $104.00K derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $92.00K 10-Q · filed 2022-05-04 | $29.00K derived: sum of 2 quarters · filed 2022-05-04 | $75.00K derived: sum of 3 quarters · filed 2022-05-04 | $28.00K derived: sum of 4 quarters · filed 2022-05-04 | ||
| 2020-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$17.00K derived: sum of 2 quarters · filed 2022-02-24 | -$64.00K derived: sum of 3 quarters · filed 2022-02-24 | -$55.00K 10-K · filed 2022-02-24 | $55.00K 10-K · filed 2021-02-25 | |
| 2020-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.00K derived: sum of 2 quarters · filed 2021-11-09 | $8.00K 10-Q · filed 2021-11-09 | $74.00K derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$38.00K 10-Q · filed 2021-07-29 | $28.00K derived: sum of 3 quarters · filed 2021-07-29 | $60.00K derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2020-03-31 | $9.00K 10-Q · filed 2021-04-30 | $75.00K derived: sum of 2 quarters · filed 2021-04-30 | $107.00K derived: sum of 3 quarters · filed 2021-04-30 | |||
| 2019-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $98.00K derived: sum of 2 quarters · filed 2021-02-25 | $115.00K 10-K · filed 2021-02-25 | |||
| 2019-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $49.00K 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $17.00K 10-Q · filed 2020-08-03 | |||||
| 2018-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$68.00K derived: sum of 2 quarters · filed 2020-03-12 | $12.00K derived: sum of 3 quarters · filed 2020-03-12 | $4.00K 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $162.00K derived: sum of 2 quarters · filed 2019-11-12 | $154.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $72.00K 10-Q · filed 2019-08-12 | ||||
| 2018-03-31 | -$8.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |